Sign In
Buy SNDL
Sundial Growers Earnings Calls
| Release date | Jul 28, 2026 |
| EPS estimate | -$0.0035 |
| EPS actual | -$0.0200 |
| EPS Surprise | -468.18% |
| Revenue estimate | 166.263M |
| Revenue actual | 165.979M |
| Revenue Surprise | -0.171% |
| Release date | Apr 29, 2026 |
| EPS estimate | -$0.0300 |
| EPS actual | -$0.0300 |
| Revenue estimate | 151.195M |
| Revenue actual | 140.841M |
| Revenue Surprise | -6.85% |
| Release date | Mar 12, 2026 |
| EPS estimate | $0.0100 |
| EPS actual | $0.0300 |
| EPS Surprise | 200.00% |
| Revenue estimate | 187.857M |
| Revenue actual | 183.87M |
| Revenue Surprise | -2.12% |
| Release date | Nov 04, 2025 |
| EPS estimate | -$0.0004 |
| EPS actual | -$0.0400 |
| EPS Surprise | -11,011.11% |
| Revenue estimate | 257.974M |
| Revenue actual | 175.1M |
| Revenue Surprise | -32.12% |
Last 4 Quarters for Sundial Growers
Below you can see how SNDL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 04, 2025 |
| Price on release | $1.86 |
| EPS estimate | -$0.0004 |
| EPS actual | -$0.0400 |
| EPS surprise | -11,011.11% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $2.16 |
| Oct 30, 2025 | $2.13 |
| Oct 31, 2025 | $2.15 |
| Nov 03, 2025 | $2.19 |
| Nov 04, 2025 | $1.86 |
| Nov 05, 2025 | $1.85 |
| Nov 06, 2025 | $1.76 |
| Nov 07, 2025 | $1.78 |
| Nov 10, 2025 | $1.87 |
| 4 days before | -13.89% |
| 4 days after | 0.538% |
| On release day | -0.538% |
| Change in period | -13.43% |
| Release date | Mar 12, 2026 |
| Price on release | $1.56 |
| EPS estimate | $0.0100 |
| EPS actual | $0.0300 |
| EPS surprise | 200.00% |
| Date | Price |
|---|---|
| Mar 06, 2026 | $1.51 |
| Mar 09, 2026 | $1.54 |
| Mar 10, 2026 | $1.56 |
| Mar 11, 2026 | $1.54 |
| Mar 12, 2026 | $1.56 |
| Mar 13, 2026 | $1.51 |
| Mar 16, 2026 | $1.44 |
| Mar 17, 2026 | $1.44 |
| Mar 18, 2026 | $1.38 |
| 4 days before | 3.31% |
| 4 days after | -11.54% |
| On release day | -3.21% |
| Change in period | -8.61% |
| Release date | Apr 29, 2026 |
| Price on release | $1.32 |
| EPS estimate | -$0.0300 |
| EPS actual | -$0.0300 |
| Date | Price |
|---|---|
| Apr 23, 2026 | $1.53 |
| Apr 24, 2026 | $1.51 |
| Apr 27, 2026 | $1.51 |
| Apr 28, 2026 | $1.47 |
| Apr 29, 2026 | $1.32 |
| Apr 30, 2026 | $1.36 |
| May 01, 2026 | $1.41 |
| May 04, 2026 | $1.42 |
| May 05, 2026 | $1.43 |
| 4 days before | -14.05% |
| 4 days after | 8.75% |
| On release day | 3.42% |
| Change in period | -6.54% |
| Release date | Jul 28, 2026 |
| Price on release | $1.22 |
| EPS estimate | -$0.0035 |
| EPS actual | -$0.0200 |
| EPS surprise | -468.18% |
| Date | Price |
|---|---|
| Jul 22, 2026 | $1.27 |
| Jul 23, 2026 | $1.25 |
| Jul 24, 2026 | $1.25 |
| Jul 27, 2026 | $1.35 |
| Jul 28, 2026 | $1.22 |
| Jul 29, 2026 | $1.20 |
| Jul 30, 2026 | $1.25 |
| Jul 31, 2026 | $1.23 |
| Aug 03, 2026 | $1.23 |
| 4 days before | -3.94% |
| 4 days after | 0.82% |
| On release day | -1.64% |
| Change in period | -3.15% |
Sundial Growers Earnings Call Transcript Summary of Q2 2026
SNDL reported Q2 2026 net revenue of $235.8M, down 3.7% YoY, driven by softness across liquor and cannabis. Gross profit fell to $56.3M (down $11.3M) and adjusted operating loss was $7.0M, pressured by cannabis production ramp-up (Jeeter), lower liquor retail sales, and a small SunStream valuation reduction. Free cash flow improved to negative $6.7M (an improvement of $1.2M YoY) and management reiterated an expectation of positive free cash flow for the full year, noting Q2 seasonality. Management emphasized cost discipline, promotional optimization, and targeted investments; they repurchased 11.7M shares in Q2 (29M+ repurchased since Q4 2024, ~7% of shares outstanding) and finished a parallel restructuring that could deliver direct control of a U.S. medical cannabis platform (Parallel) with ~56 retail locations and ~CAD 150M near-term annualized revenue, subject to regulatory/closing conditions. Balance sheet strength: $183.2M unrestricted cash, no debt, and CAD $415.2M carrying value of cannabis-related investments. Key near-term risks/opportunities: persistent production inefficiencies in cannabis operations (Jeeter ramp) likely to pressure margins in coming months, ongoing softness in liquor same-store sales, and optionality for U.S. expansion (Florida, Texas, Massachusetts) alongside continued disciplined capital allocation (share buybacks, selective investments).
